o The prescribing information for the requested medication has been thoroughly Vyondys 53 (golodirsen) [package insert]. Cambridge, MA: Sarepta
Vyondys 53 [package insert]. Cambridge, MA. Sarepta Therapeutics, Inc. December 2024. 3. Viltepso [package insert]. Paramus, NJ; NS Pharma
Givlaari [package insert]. Cambridge, MA: Alnylam Pharmaceuticals Vyondys 53 [package insert]. Cambridge, MA: Sarepta Therapeutics, Inc.; Dec
Exondys 51 (eteplirsen injection) [package insert] Cambridge, MA: Sarepta Therapeutics, Inc.; 2024. 12. Vyondys 53 (golodirsen injection) [package insert]
Absence of unacceptable toxicity from the drug. Examples of 1. Vyondys 53 [package insert]. Cambridge, MA; Sarepta Therapeutics
Absence of unacceptable toxicity from the drug. Examples of Vyondys 53 [package insert]. Cambridge, MA; Sarepta Therapeutics
AMONDYS 45 [package insert]. Cambridge, MA: Sarepta Therapeutics, Inc.; 2024. 3. VILTEPSO [package insert]. Paramus, NJ: NS Pharma, Inc.; 2024. 4. VYONDYS
5. Patient will not use golodirsen (Vyondys 53 ) together with Viltolarsen [Viltepso ]) Renewal Approval: 6 months References: 1. Vyondys 53 [package insert]. Cambridge, MA: Sarepta Therapeutics, Inc.; March 2024. 2. Viltepso [package insert]. NS Pharma, Inc. Paramus, NJ 3. Clinical Pharmacology [database online].
DRUG NAME. Vyondys 53 (golodirsen). BILLING CODE. J1429 Removed ambulatory requirement. References: 1. Vyondys 53 [Package Insert].
I would like to know more about this package. ^.^